LAG3 and breast carcinoma: The soluble form of LAG-3 was detectable only in small amounts in the HTM, although elevated LAG-3 expression was found on the CD4 and CD8 T cells in the MDA-MB-231 HTM and PDX model as well as in the dataset of breast cancer patient samples.